Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct;12(4):229-237.
doi: 10.34172/mejdd.2020.187.

Novel Therapeutic Strategies for Celiac Disease

Affiliations
Review

Novel Therapeutic Strategies for Celiac Disease

Nastaran Asri et al. Middle East J Dig Dis. 2020 Oct.

Abstract

Celiac disease (CeD) is a widespread autoimmune enteropathy caused by dietary gluten peptides in genetically susceptible individuals, which includes a range of intestinal and extraintestinal manifestations. Currently, there is no effective treatment for CeD other than strict adherence to a gluten-free diet (GFD). However, persistent or frequent symptoms and also partial villus atrophy were observed in some patients with CeD due to intentional or inadvertent gluten exposure during the use of GFD. It means that GFD alone is not enough to control CeD symptoms and long-term complications. Accordingly, new therapeutic approaches for CeD treatment such as gluten proteolysis, removing gluten from the digestive tract, promoting tight junction assembly, inhibiting intestinal tissue transglutaminase 2, using probiotics, and developing immunotherapeutic methods have been proposed through different strategies. This review focused on discussing the novel therapeutic strategies for CeD management.

Keywords: Auto-immune; Celiac disease; Diet; Gluten; Gluten-free; Therapy; Villous atrophy.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST The authors declare no conflict of interest related to this work.

References

    1. Mo1 Mo1. Mo1Mahadov SGreen PHCeliac disease: a challenge for all physicians. Gastroenterol Hepatol. 2011;7:554–6. - PMC - PubMed
    1. Gujral N, Freeman HJ, Thomson AB. Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol. 2012;18:6036–59. doi: 10.3748/wjg.v18.i42.6036. - DOI - PMC - PubMed
    1. Asri N, Rostami-Nejad M. The Facts of Celiac Disease; A Comprehensive Review. Int J Celiac Dis. 2019;7:48–52. doi: 10.12691/ijcd-7-2-7. - DOI
    1. Rostami Nejad M, Karkhane M, Marzban A, Nazemalhosseini Mojarad E, Rostami K. Gluten related disorders. Gastroenterol Hepatol Bed Bench. 2012;5:S1–7. - PMC - PubMed
    1. Wieser H, Koehler P. The Biochemical Basis of Celiac Disease. Cereal Chem. 2008:85. doi: 10.1094/CCHEM-85-1-0001. - DOI

LinkOut - more resources